Back
Hennessy Advisors 10K Form
Buy
55
HNNA
Hennessy Advisors
Last Price:
11.80
Seasonality Move:
4.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | HNNA/Hennessy Advisors Quarterly |
2024-02-08 | 10Q | HNNA/Hennessy Advisors Quarterly |
2023-08-02 | 10Q | HNNA/Hennessy Advisors Quarterly |
2023-05-10 | 10Q | HNNA/Hennessy Advisors Quarterly |
2023-02-09 | 10Q | HNNA/Hennessy Advisors Quarterly |
2022-08-03 | 10Q | HNNA/Hennessy Advisors Quarterly |
Receive HNNA News And Ratings
See the #1 stock for the next 7 days that we like better than HNNA
HNNA Financial Statistics
Sales & Book Value
Annual Sales: | $29.65M |
---|---|
Cash Flow: | $3.34M |
Price / Cash Flow: | 10.21 |
Annual Sales: | $11.74 |
Price / Book: | 1.01 |
Profitability
EPS (TTM): | 0.92000 |
---|---|
Net Income (TTM): | $7.1M |
Gross Margin: | $15.6M |
Return on Equity: | 7.95% |
Return on Assets: | 4.8% |
Hennessy Advisors Earnings Forecast
Key Hennessy Advisors Financial Ratios
- The Gross Profit Margin over the past 18 years for HNNA is 52.60%.
- The Selling, General & Administrative Expenses for HNNA have been equal to 21.87% of Gross Profit Margin.
- The Interest Expense is 32.06% of Operating Income.
- The Net Earning history of HNNA is 23.94% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 15 years.
Hennessy Advisors Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | HNNA |
CUSIP: | 425885 |
Website: | hennessyadvisors.com |
Debt
Debt-to-Equity Ratio: | 0.43 |
---|---|
Current Ratio: | 13.78 |
Quick Ratio: | 13.62 |
Price-to-Earnings
Trailing P/E Ratio: | 12.88 |
---|---|
Forward P/E Ratio: | 0 |
HNNA Technical Analysis vs Fundamental Analysis
Buy
55
Hennessy Advisors (HNNA)
is a Buy
Is Hennessy Advisors a Buy or a Sell?
-
Hennessy Advisors stock is rated a Buy
The current Hennessy Advisors [HNNA] share price is $11.85. The Score for HNNA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.